1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Multivariable linear mixed-effects modeling of CBF based on clinical, demographic, and study factorsa
Mod_Baseline Mod_HCP Mod_HCPCMS (Intercept) 43.3 (3.86)b 48.4 (4.06)b 50.1 (4.70)b Postop time point 6.21 (2.00)c 3.01 (2.08) 1.55 (2.20) Follow-up time point 14.8 (2.07)b 10.5 (2.15)b 7.74 (2.31)b Age −0.686 (0.45) −1.17 (0.53)d −1.34 (0.59)d Thalamus −5.55 (1.60)b −5.59 (1.51)b −5.60 (1.45)b Cerebellum −10.0 (1.59)b −10.0 (1.50)b –10.0 (1.44)b Unsedated (vs GA) – 3.57 (3.79) 5.73 (3.93) Hydrocephalus – −19.4 (6.04)c −20.5 (6.27)c Postop time point + HCP – 21.5 (5.17)b 24.0 (5.13)b Follow-up time point + HCP – 26.0 (5.22)b 27.2 (5.18)b CMS – – −10.9 (6.46)e Postop time point + CMS – – 8.74 (5.26)e Follow-up time point + CMS – – 15.6 (5.28)c AIC 1841.5 1824.7 1821.8 Marginal R2 0.224 0.290 0.295 Conditional R2 0.607 0.650 0.692